These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9815758)

  • 1. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.
    Wilcken NR; Prall OW; Musgrove EA; Sutherland RL
    Clin Cancer Res; 1997 Jun; 3(6):849-54. PubMed ID: 9815758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
    Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
    Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
    Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
    Wilcken NR; Sarcevic B; Musgrove EA; Sutherland RL
    Cell Growth Differ; 1996 Jan; 7(1):65-74. PubMed ID: 8788034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
    Foster JS; Wimalasena J
    Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.
    Prall OW; Rogan EM; Musgrove EA; Watts CK; Sutherland RL
    Mol Cell Biol; 1998 Aug; 18(8):4499-508. PubMed ID: 9671459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.
    Carlson B; Lahusen T; Singh S; Loaiza-Perez A; Worland PJ; Pestell R; Albanese C; Sausville EA; Senderowicz AM
    Cancer Res; 1999 Sep; 59(18):4634-41. PubMed ID: 10493518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.
    Pacilio C; Germano D; Addeo R; Altucci L; Petrizzi VB; Cancemi M; Cicatiello L; Salzano S; Lallemand F; Michalides RJ; Bresciani F; Weisz A
    Cancer Res; 1998 Mar; 58(5):871-6. PubMed ID: 9500441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
    Musgrove EA; Hamilton JA; Lee CS; Sweeney KJ; Watts CK; Sutherland RL
    Mol Cell Biol; 1993 Jun; 13(6):3577-87. PubMed ID: 8497271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells.
    Kilker RL; Hartl MW; Rutherford TM; Planas-Silva MD
    J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):63-71. PubMed ID: 15544931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells.
    Hong J; Shah NN; Thomas TJ; Gallo MA; Yurkow EJ; Thomas T
    Oncol Rep; 1998; 5(5):1025-33. PubMed ID: 9683804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
    Musgrove EA; Wakeling AE; Sutherland RL
    Cancer Res; 1989 May; 49(9):2398-404. PubMed ID: 2706627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
    Musgrove EA; Lee CS; Cornish AL; Swarbrick A; Sutherland RL
    Mol Endocrinol; 1997 Jan; 11(1):54-66. PubMed ID: 8994188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.